Early diagnosis and precision treatment of right ovarian vein and inferior vena cava thrombosis following caesarean section: A case report

Cao,Weiping; Ni,Xia; Wang,Qin; Li,Jie; Li,Yan; Chen,Tingmei; Wang,Xinzhi

doi:10.3892/etm.2020.8548

Early diagnosis and precision treatment of right ovarian vein and inferior vena cava thrombosis following caesarean section: A case report

Authors:
- Weiping Cao
- Xia Ni
- Qin Wang
- Jie Li
- Yan Li
- Tingmei Chen
- Xinzhi Wang
View Affiliations

Affiliations: Department of Obstetrics, Maternity and Child Health Hospital of Zhenjiang, Zhenjiang, Jiangsu 212001, P.R. China, Department of Imaging, Maternity and Child Health Hospital of Zhenjiang, Zhenjiang, Jiangsu 212001, P.R. China, Department of Nursing, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China, Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, Jiangsu 210009, P.R. China
Published online on: February 25, 2020 https://doi.org/10.3892/etm.2020.8548
Pages: 2923-2926
Copyright: © Cao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ovarian vein thrombosis (OVT) is a rare medical complication that is most often diagnosed in the post‑partum period. OVT can lead to conditions, including sepsis, inferior vena cava (IVC), pulmonary emboli and mortality. The current study outlines a case of a patient who experienced pain in the lower abdomen and waist without fever postpartum following caesarean section (CS). Plasma FDP, D‑Dimer and fibrinogen levels were markedly increased following CS and this was an indicator of the rapid progression of blood coagulation and fibrinolysis. Increased maternal lipid may be one of the risk factors for thrombosis. Based on the clinical presentation, a CT scan demonstrated thrombosis of the right ovarian vein and inferior vena cava, and a diagnosis of OVT and IVC thrombosis was subsequently made. In the current case, an anticoagulant therapy was started with a subcutaneous injection low molecular weight heparin calcium, an intravenous urokinase drip as a thrombolytic agent and implantation of inferior vena cava filters as a novel method of treatment for thrombosis. The patient was discharged from hospital 20 days following treatment in a good condition. The current study reports a case of OVT associated with IVC that was successfully managed without complication.

View Figures

View References

1	Jenayah AA, Saoudi S, Boudaya F Bouriel I, Sfar E and Chelli D: Ovarian vein thrombosis. Pan Afr Med J. 21(251)2015.PubMed/NCBI View Article : Google Scholar
2	Plastini T, Henry D and Dunleavy K: Ovarian vein thrombus: To treat or not to treat? Blood Advance. 1:1120–1123. 2017.PubMed/NCBI View Article : Google Scholar
3	Rottenstreich A, Da'as N, Kleinstern G, Spectre G, Amsalem H and Kalish Y: Pregnancy and non-pregnancy related ovarian vein thrombosis: Clinical course and outcome. Thromb Res. 146:84–88. 2016.PubMed/NCBI View Article : Google Scholar
4	See A and Chern B: Contained intra-abdominal morcellation: Is it the way forward? Gynecol Minim Invasive Ther. 5:99–101. 2016. View Article : Google Scholar
5	Bates SM, Middeldorp S, Rodger M, James AH and Greer I: Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis. 41:92–128. 2016.PubMed/NCBI View Article : Google Scholar
6	Assal A, Kaner JD, Danda N, Cohen HW and Billett HH: Risk factors and prognosis of ovarian vein thrombosis. Blood Coagul Fibrinolysis. 28:468–474. 2017.PubMed/NCBI View Article : Google Scholar
7	Cassinelli G and Naggi A: Old and new applications of non-anticoagulant heparin. Int J Cardiol. 212 (Suppl)(S14-S21)2016.PubMed/NCBI View Article : Google Scholar
8	Bos AS, Tullius T, Patel M, Leef JA, Navuluri R, Lorenz JM and Van Ha TG: Indwelling and retrieval complications of Denali and celect infrarenal vena cavafilters. J Vasc Interv Radiol. 27:1021–1026. 2016.PubMed/NCBI View Article : Google Scholar
9	Iliodromiti S, Mackay DF, Smith GC, Pell JP and Nelson SM: Apgar score and the risk of cause-specific infant mortality: A population-based cohort study. Lancet. 384:1749–1755. 2014.PubMed/NCBI View Article : Google Scholar
10	Murphy EH, Johns B, Varney E and Raju S: Endovascular management of chronic total occlusions of the inferior vena cava and iliac veins. J Vasc Surg Venous Lymphat Disord. 5:47–59. 2017.PubMed/NCBI View Article : Google Scholar
11	Dargaud Y, Rugeri L, Fleury C Battie C, Gaucherand P, Huissoud C, Rudigoz RC, Desmurs-Clavel H, Ninet J and Trzeciak MC: Personalized thromboprophylaxis using a risk score for the management of pregnancies with high risk of thrombosis: A prospective clinical study. J Thromb Haemost. 15:897–906. 2017.PubMed/NCBI View Article : Google Scholar
12	Streiff MB, Agnelli G, Connors JM Crowther M, Eichinger S, Lopes R, McBane RD, Moll S and Ansell J: Guidance for the treatment of deep vein thrombosis and pulmonary embolism. J Thromb Thrombolysis. 41:32–67. 2016.PubMed/NCBI View Article : Google Scholar
13	Morelli VM, Lijfering WM, Bos MHA, Rosendaal FR and Cannegieter SC: Lipid levels and risk of venous thrombosis: Results from the MEGA-study. Eur J Epidemiol. 32:669–681. 2017.PubMed/NCBI View Article : Google Scholar
14	Wendelboe AM and Raskob GE: Global burden of thrombosis: Epidemiologic aspects. Circ Res. 118:1340–1347. 2016.PubMed/NCBI View Article : Google Scholar
15	Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, et al: Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 149:315–352. 2016.PubMed/NCBI View Article : Google Scholar
16	Farge D and Frere C: Clinical practice guidelines for prophylaxis of venous thromboembolism in cancer patients. Thromb Haemost. 116:618–625. 2016.
17	Djakovic I, Mustapic M, Marleku F, Grgic O, Djakovic Z and Kosec V: Ovarian vein thrombosis-a case report. Acta Clinica Belg. 70:445–446. 2015. View Article : Google Scholar
18	Hong-Kee N, Mei-Fong C, Azhany Y and Zunaina E: Antiphospholipid syndrome in lupus retinopathy. Clin Ophthalmo. 8:2359–2363. 2014.PubMed/NCBI View Article : Google Scholar
19	Girolami A, Treleani M, Bonamigo E, Tasinato V and Girolami B: Venous thrombosis in rare or unusual sites: A diagnostic challenge. Semin Thromb Haemost. 40:81–87. 2014.PubMed/NCBI View Article : Google Scholar
20	Liu M and Zhang F: Administration routes affect thrombolytic effect of catheter-directed thrombolysis with pro-urokinase in treating deep vein thrombosis. Ann Transl Med. 6(322)2018.PubMed/NCBI View Article : Google Scholar
21	Harris SA, Velineni R and Davies AH: Inferior vena cava filters in pregnancy: A systematic review. J Vasc Interv Radio. 27(354-360.e8)2016.PubMed/NCBI View Article : Google Scholar
22	Angelini M, Barillari G, Londero AP, Bertozzi S, Bernardi S, Petri R, Driul L and Marchesoni D: Puerperal ovarian vein thrombosis: Two case reports. J ThrombThrombolysis. 35:286–289. 2013.PubMed/NCBI View Article : Google Scholar
23	Wan Z, Xiang R, Wang H, Zhong Q and Tu B: Comparative efficacy and safety of local and peripheral venous thrombolytic therapy with urokinase for thrombosed hemodialysis arteriovenous fistulas. Exp Ther Med. 17:4279–4284. 2019.PubMed/NCBI View Article : Google Scholar
24	Bikdeli B, Chatterjee S, Desai NR, Kirtane AJ, Desai MM, Bracken MB, Spencer FA, Monreal M, Goldhaber SZ and Krumholz HM: Inferior vena cava filters to prevent pulmonary embolism: Systematic review and meta-analysis. J Am Coll Cardiol. 70:1587–1597. 2017.PubMed/NCBI View Article : Google Scholar
25	Watson L, Broderick C and Armon MP: Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev. 11(CD002783)2016.PubMed/NCBI View Article : Google Scholar